Maternal and Infant Outcomes After Human Papillomavirus Vaccination in the Periconceptional Period or During Pregnancy

OBJECTIVE: To evaluate whether quadrivalent human papillomavirus vaccine (4vHPV) administered during the periconceptional period or during pregnancy was associated with increased risks for adverse obstetric events, adverse birth outcomes, or selected major structural birth defects. METHODS: We condu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Obstet Gynecol
Main Authors: Lipkind, Heather S., Vazquez-Benitez, Gabriela, Nordin, James D., Romitti, Paul A., Naleway, Allison L., Klein, Nicola P., Hechter, Rulin C., Jackson, Michael L., Hambidge, Simon J., Lee, Grace M., Sukumaran, Lakshmi, Kharbanda, Elyse O.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6496947/
https://ncbi.nlm.nih.gov/pubmed/28796684
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/AOG.0000000000002191
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados